Share

Latest Documents


  • 22-January-2024

    English

    Unique Identifier for Transgenic Plants

    The OECD developed the BioTrack Product Database which accommodates Unique Identifiers to each transgenic (or genetically engineered) plant that is approved for commercial use, including planting and food/feed use. These Unique Identifiers are intended to be used as "keys" to access information of each transgenic product in this database and to ensure the safety of modern biotechnology products

    Related Documents
  • 30-June-2023

    English

    OECD Biotechnology Update

    Read our newsletter to stay up-to-date with all the latest OECD work on biotechnology.

    Related Documents
  • 15-March-2023

    English

    Safety of novel foods and feeds and on the harmonisation of regulatory oversight in biotechnology

    These two documents compile information on activities related to the assessment of the safety of products derived from modern biotechnology, environmental safety (biosafety) and the safety of novel foods and feeds, at the international level between April 2021 and May 2022. The information was provided by OECD Members, partner countries and observer organisations participating in the work.

    Related Documents
  • 3-May-2022

    English

    Safety Assessment of Transgenic Organisms: OECD Consensus Documents

    The OECD biosafety consensus documents identify elements of scientific information used in the environmental safety and risk assessment of transgenic organisms which are common to OECD member countries.

    Related Documents
  • 28-January-2019

    English

    Saving Costs in Chemicals Management - How the OECD Ensures Benefits to Society

    The chemical industry is one of the largest industrial sectors in the world and is expected to grow fourfold by 2060. Indeed modern life without chemicals would be inconceivable. Given the potential environmental and human health risks from exposure to chemicals, governments and industry have a major responsibility to ensure that chemicals are produced and used safely. The OECD assists countries in developing and implementing policies and instruments that protect human health and the environment, and in making their systems for managing chemicals as efficient as possible. To eliminate duplication of work and avoid non-tariff barriers to trade, emphasis has been on developing shared frameworks for gathering and assessing information on potential chemical risks. The time-tested OECD Mutual Acceptance of Data (MAD) system provides a major basis for generating savings to governments and industry. This report provides an overview of the benefits and estimates the total savings from OECD work to be more than EUR 309 million per year.
  • 17-December-2018

    English

    Consensus documents: work on harmonisation of regulatory oversight in biotechnology

    These documents focus on the biology of organisms (such as plants, trees or micro-organisms) or introduced novel traits.

    Related Documents
  • 28-June-2018

    English

    Genome Editing: Applications in Agriculture

    The OECD Conference on Genome Editing: Applications in Agriculture – Implications for Health, Environment and Regulation will explore the regulatory considerations raised by genome edited products, with the aim to favour a coherent policy approach to facilitate innovation involving genome editing. More information on the programme and the speakers.

    Related Documents
  • 23-June-2018

    English

    Safety Assessment of Transgenic Organisms in the Environment, Volume 8 - OECD Consensus Document of the Biology of Mosquito Aedes aegypti

    Volume 8 of the Series contains the first biosafety ‘consensus document’ to deal with the biology of an insect, the mosquito Aedes aegypti. Issued by the OECD Working Group on the Harmonisation of Regulatory Oversight in Biotechnology, the science-based consensus documents collate information for use during the regulatory risk assessment of biotechnology products, i.e. transgenic organisms (plants, animals, micro-organisms) when intended for release in the environment. Ae. aegypti mosquito is vectoring yellow fever, dengue, Zika and Chikungunya diseases in tropical and sub-tropical regions worldwide. Biotechnological applications are developed to control the mosquito population and reduce virus transmission. The book provides information on Ae. aegypti taxonomy, morphology, life cycle, reproductive biology, genetics, ecology, interactions with other species and the environment. The mosquito effects on human and animal health, and the control strategies/specific programmes to limit its development are also summarised.
  • 21-December-2017

    English

    Safety Assessment of Transgenic Organisms in the Environment, Volume 7 - OECD Consensus Documents

    Volume 7 of the Series compiles the OECD consensus documents for use in environmental risk assessment of transgenic organisms (biosafety) issued in 2016 and 2017. The first two chapters cover the biology of plant species (sorghum and tomato) and include elements of taxonomy, centres of origin, reproductive biology, genetics, outcrossing, crop production and cultivation practices, interactions with other organisms, main pests and pathogens, and biotechnological developments. The third chapter relates to Atlantic salmon, the first OECD biosafety publication to address an animal species. It describes the biology and ecology of wild salmon (including classification, life stages, reproduction, centres of origin, geographical distribution, population dynamics, interaction with other organisms) and of the farmed form (domestication, aquaculture rearing practices, biocontainment, interactions with the external environment). It also provides elements of genetics, research on genetically engineered salmon and resources for its risk assessment.
  • 6-December-2017

    English

    BioTrack Product Database

    This OECD database allows regulatory officials and stakeholders to share information on products derived from the use of modern biotechnology, as well as some products with novel traits acquired by the use of conventional breeding or mutagenesis, that have been approved for commercial application in at least one country, in terms of food, feed or environmental safety.

    Related Documents
  • 1 | 2 | 3 | 4 > >>